Sign in
IDP Stock Price, Chart, Stats & News
Biogen Inc.
Save
Biogen Inc. (IDP) does not currently pay a dividend.
24.46B
Market cap
20.71x
Current P/E
13.79x
Forward P/E
IDP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - General
Industry
Biogen Inc. is a prominent biopharmaceutical company dedicated to the research, development, production, and commercialization of therapeutic solutions for neurological and neurodegenerative disorders. Its extensive product lineup features treatments for multiple sclerosis (MS), including TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA. For spinal muscular atrophy, the company offers SPINRAZA, and FUMADERM addresses plaque psoriasis.
Similar securities
Based on sector and market capitalization
Report issue